Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/235430
Full metadata record
DC FieldValueLanguage
dc.contributor.CRUESPUNIVERSIDADE DE ESTADUAL DE CAMPINASpt_BR
dc.typeArtigo de periódicopt_BR
dc.title[treatment Of Status Migrainosus By General Anesthesia: A Case Report].pt_BR
dc.contributor.authorUdelsmann, Arturpt_BR
dc.contributor.authorSaccomani, Priscilapt_BR
dc.contributor.authorDreyer, Elisabethpt_BR
dc.contributor.authorCosta, Alberto Luiz Cunha dapt_BR
unicamp.authorArtur Udelsmann, Departamento de Anestesiologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, SP, Brasil. Electronic address: au1849@gmail.com.pt_BR
unicamp.authorPriscila Saccomani, Serviço de Anestesia, Hospital das Clínicas, Universidade Estadual de Campinas, Campinas, SP, Brasil.pt_BR
unicamp.authorElisabeth Dreyer, Hospital das Clínicas, Universidade Estadual de Campinas, Campinas, SP, Brasil.pt_BR
unicamp.authorAlberto Luiz Cunha da Costa, Ambulatório de Cefaleia, Hospital das Clínicas, Universidade Estadual de Campinas, Campinas, SP, Brasil.pt_BR
dc.subjectAnestesia Geralpt_BR
dc.subjectCombined Therapypt_BR
dc.subjectGeneral Anesthesiapt_BR
dc.subjectMigraine Disorderpt_BR
dc.subjectTerapia Combinadapt_BR
dc.subjectTranstorno De Enxaquecapt_BR
dc.description.abstractThe status migrainosus is a complication of migraine characterizedby severe headache for more than 72 h that did not respond to treatment, with risk of strokeand suicide. Researches on treatment are directed to drugs that stimulate GABA receptors; propofol and isoflurane act on sub-GABAa receptors and theoretically could be interesting. The first has been the subject of research in severe migraine. Opioids are employed in pain, and its use in chronic headache is debatable, but these agents are employed in acute cases. The goalis to present a case of refractory status migrainosus in that we decided to break the pain cycle by general anesthesia. Female patient, aged 50 years, with status migrainosus, in the last five days withvisits to the emergency department, medicated parenterally with various agents without result. Without comorbidities, dehydrated, described her pain as well over 10 in Visual NumericScale (VNS). After consulting the literature, and given the apparent severity of the condition, we opted for a general anesthesia: induction with fentanyl, propofol, and vecuroniumand maintenance with isoflurane and propofol for two hours. Following the treatment, in the postanesthetic recuperation (PAR), the patient related her pain as VNS 3, and was released after five hours with VNS 2. Subsequently, her preventive treatment was resumed. Status migrainosus is a rare disabling complication and anesthetics have been the subject of research in its treatment; the option for general anesthesia with agents that stimulate GABA receptors, propofol and isoflurane, in association with fentanyl, proved effective and should encourage new research.en
dc.relation.ispartofRevista Brasileira De Anestesiologiapt_BR
dc.relation.ispartofabbreviationRev Bras Anestesiolpt_BR
dc.identifier.citationRevista Brasileira De Anestesiologia. v. 65, n. 5, p. 407-410pt_BR
dc.language.isoporpt_BR
dc.description.volume65pt_BR
dc.description.firstpage407-410pt_BR
dc.rightsembargopt_BR
dc.sourcePubMedpt_BR
dc.identifier.issn1806-907Xpt_BR
dc.identifier.doi10.1016/j.bjan.2013.09.010pt_BR
dc.identifier.urlhttp://www.ncbi.nlm.nih.gov/pubmed/?term=26363696pt_BR
dc.date.available2016-05-23T19:41:01Z-
dc.date.accessioned2016-05-23T19:41:01Z-
dc.description.provenanceMade available in DSpace on 2016-05-23T19:41:01Z (GMT). No. of bitstreams: 1 pmed_26363696.pdf: 222724 bytes, checksum: 9287369ad4df94ae5821f430c30274ef (MD5) Previous issue date: nullen
dc.identifier.urihttp://repositorio.unicamp.br/jspui/handle/REPOSIP/235430-
dc.identifier.idPubmed26363696pt_BR
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
pmed_26363696.pdf217.5 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.